title: How relevant were the models used to measure the impact of Panton-Valentine leukocidin in human staphylococcal infections?
authors.forename: W A
authors.initials: WA
authors.lastname: Schwartzman
authors.forename: D O
authors.initials: DO
authors.lastname: Beenhouwer
authors.forename: D R
authors.initials: DR
authors.lastname: Schaberg
mesh_terms: D000038:Abscess / Q000382:microbiology; D000818:Animals; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D017714:Community-Acquired Infections / Q000382:microbiology; D004195:Disease Models, Animal; D005098:Exotoxins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007956:Leukocidins / Q000235:genetics / Q000378:metabolism*; D016106:Methicillin Resistance; D051379:Mice; D011817:Rabbits; D018805:Sepsis / Q000382:microbiology; D013203:Staphylococcal Infections / Q000382:microbiology / Q000473:pathology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D014774:Virulence
chemical_list: D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin